466 related articles for article (PubMed ID: 12917905)
21. Regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Cates MJ
Cochrane Database Syst Rev; 2008 Jul; (3):CD006363. PubMed ID: 18646149
[TBL] [Abstract][Full Text] [Related]
22. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
23. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
24. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Evans DJ; Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
[TBL] [Abstract][Full Text] [Related]
25. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
Sestini P; Renzoni E; Robinson S; Poole P; Ram FS
Cochrane Database Syst Rev; 2002; (4):CD001495. PubMed ID: 12519559
[TBL] [Abstract][Full Text] [Related]
26. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma.
Welsh EJ; Cates CJ
Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD008418. PubMed ID: 20824877
[TBL] [Abstract][Full Text] [Related]
27. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Sao Paulo Med J; 2010; 128(5):310-1. PubMed ID: 21181075
[TBL] [Abstract][Full Text] [Related]
28. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
Sovani MP; Whale CI; Tattersfield AE
Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
[TBL] [Abstract][Full Text] [Related]
29. Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.
Cates CJ; Oleszczuk M; Stovold E; Wieland LS
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD010005. PubMed ID: 23076961
[TBL] [Abstract][Full Text] [Related]
30. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2012 Mar; 3(3):CD007695. PubMed ID: 22419326
[TBL] [Abstract][Full Text] [Related]
31. Salmeterol versus theophylline in the treatment of asthma.
Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
[TBL] [Abstract][Full Text] [Related]
32. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
33. Inhaled bronchodilators for cystic fibrosis.
Halfhide C; Evans HJ; Couriel J
Cochrane Database Syst Rev; 2005 Oct; (4):CD003428. PubMed ID: 16235319
[TBL] [Abstract][Full Text] [Related]
34. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
Welsh EJ; Cates CJ; Poole P
Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
[TBL] [Abstract][Full Text] [Related]
35. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.
Travers AH; Jones AP; Camargo CA; Milan SJ; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010256. PubMed ID: 23235686
[TBL] [Abstract][Full Text] [Related]
36. Regular treatment with formoterol for chronic asthma: serious adverse events.
Cates CJ; Cates MJ; Lasserson TJ
Cochrane Database Syst Rev; 2008 Oct; (4):CD006923. PubMed ID: 18843738
[TBL] [Abstract][Full Text] [Related]
37. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.
Nannini LJ; Cates CJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2007 Oct; (4):CD006829. PubMed ID: 17943918
[TBL] [Abstract][Full Text] [Related]
38. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
39. Regular treatment with formoterol for chronic asthma: serious adverse events.
Cates CJ; Cates MJ
Cochrane Database Syst Rev; 2012 Apr; 4(4):CD006923. PubMed ID: 22513944
[TBL] [Abstract][Full Text] [Related]
40. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
